Gene expression profiles of endothelial progenitor cells by oligonucleotide microarray analysis
Souichi Furuhata1, Kiyoshi Ando, Masayuki Oki
1Genetics Division, National Cancer Center Research Institute, Tokyo, Japan.
Molecular and Cellular Biochemistry
|January 5, 2007
Summary
Endothelial progenitor cells (EPCs) from umbilical cord blood were analyzed for gene expression. Researchers identified key genes critical for EPC function and survival, offering potential therapeutic targets for vascular diseases and cancer.
Area of Science:
- * Molecular Biology
- * Stem Cell Research
- * Vascular Biology
Background:
- * Endothelial progenitor cells (EPCs) play a crucial role in vascular biology and embryology.
- * EPCs hold therapeutic potential for postnatal diseases like cardiovascular disorders, peripheral vascular disorders, and cancer.
- * Characterizing EPCs at a molecular level is essential for understanding their function and therapeutic applications.
Purpose of the Study:
- * To provide comprehensive information on the gene expression profile of EPCs.
- * To identify key genes involved in EPC function and survival.
- * To characterize EPCs derived from CD34-positive mononuclear cells of human umbilical cord blood in molecular terms.
Main Methods:
- * Purification and expansion of EPCs from human umbilical cord blood.
- * Analysis of gene expression using high-density oligonucleotide microarrays.
- * Validation of gene expression using real-time RT-PCR and in situ hybridization.
Main Results:
- * Identified 169 up-regulated and 107 down-regulated genes in EPCs compared to differentiated endothelial cells (HUVEC, LMEC, AoEC).
- * Found increased expression of Syk and galectin-3 in EPCs, suggesting their importance in EPC function.
- * Demonstrated expression of identified genes in fetal liver during mouse development, indicating their role in vasculogenesis.
Conclusions:
- * The identified gene list provides critical insights into EPC function, survival, and potential therapeutic targets.
- * Syk and galectin-3 are highlighted as key genes with higher expression in EPCs.
- * These findings support the potential of EPCs in therapeutic strategies for diseases involving de novo vasculogenesis.


